Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pathologic Complete Response × Fluorouracil × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 104 Colonic Neoplasms 57 Rectal Neoplasms 51 Breast Neoplasms 49 Stomach Neoplasms 30 Pancreatic Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 22 Neoplasm Metastasis 20 Head and Neck Neoplasms 19 Esophageal Neoplasms 19 Esophageal Squamous Cell Carcinoma 14 Adenocarcinoma Of Esophagus 13 Carcinoma, Hepatocellular 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Neoplasms 10 Nasopharyngeal Carcinoma 10 Adenocarcinoma 6 Keratosis, Actinic 5 Anus Neoplasms 5 Urinary Bladder Neoplasms 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Cholangiocarcinoma 4 Inflammatory Breast Neoplasms 3 Hypopharyngeal Neoplasms 3 Hepatoblastoma 3 HIV Infections 3 Anal Canal Carcinoma 3 Uterine Cervical Neoplasms 2

Interventions

Cyclophosphamide 3 Epirubicin 2 Docetaxel 2 Carboplatin 2 Capecitabine 2 Azacitidine 2 venetoclax 1 tegafur-gimeracil-oteracil 1 taxane 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pirarubicin 1 pertuzumab 1 pembrolizumab 1 olaparib 1 cc-486 1 Trastuzumab 1 Thalidomide 1 Radiotherapy 1 Radiation 1 Platinum 1 Paclitaxel 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Monatide (IMS 3015) 1 Methotrexate 1 Magnetic Resonance Imaging 1 Leucovorin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡